Pfizer Testing Oral Covid Treatment — Would Be First To Market

  • 📰 Forbes
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

After bringing the first vaccine to market, Pfizer hopes for the next breakthrough

a stage one clinical trial on an oral antiviral therapy that a Covid-19 patient could take when they first develop symptoms, which would make it the first oral antiviral treatment for coronavirus. ... [+]

Pfizer has been working with the company Biontech on the development of a Covid 19 vaccine. Photo: Christophe Gateau/dpa The trial is being conducted in the U.S. and relies on protease inhibitors—the same kind ofThe trial is randomized and includes placebo groups with both single and multiple-dose studies.

The company is also studying an intravenous antiviral to treat Covid-19, which is now being used on clinical trial patients hospitalized with Covid-19. “Together, the two [oral and intravenous antivirals] have the potential to create an end to end treatment paradigm that complements vaccination,” Pfizer chief scientific officer Mikael Dolsten said.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 394. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

“O you who have believed, enter into peacefulness, the whole (of you), and do not follow the footsteps of Satan. Indeed, he is to you a clear enemy.” Quran: [2:208]. The Quran is The Final Word From God; The Creator Of Everything.

France Dernières Nouvelles, France Actualités